NKG2A–HLA-E and TIM3–galectin 9 pathways promote immune inhibition and represent therapeutic vulnerabilities in pancreatic ductal adenocarcinoma
Cancer Immunology, Immunotherapy · 2026
DOI: 10.1007/s00262-026-04479-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, 2026. Verfasst von Yuanyu Lin und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, NK Cell Lectin-Like Receptor Subfamily C, Hepatitis A Virus Cellular Receptor 2, Pancreatic Neoplasms. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shenzhen Science and Technology Innovation Program, National Natural Science Foundation of China, Shenzhen Medical Research Fund.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China.
- Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, No. 628, Zhenyuan Road, Guangming, Shenzhen, 518107, Guangdong, China.
- Digestive Diseases Center, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China.
- Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China.
- Department of Pathology, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China.
- Department of General Surgery, The Seventh Affiliated Hospital of Sun Yat-Sen University, Shenzhen, Guangdong, China. tangdi@mail.sysu.edu.cn.
Förderung
- Shenzhen Science and Technology Innovation Program
- National Natural Science Foundation of China
- Shenzhen Medical Research Fund
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Lin, Y., Feng, W., Li, Y., Tang, Y., Zhuang, X., Huang, Y., Xie, J., Liu, K., Fan, Y., Tang, Y., Li, D., He, Z., Qiu, Y., Chen, J., Xu, J., Yang, Z., Lan, L., Tang, D., Deng, G., & Zhou, G. (2026). NKG2A–HLA-E and TIM3–galectin 9 pathways promote immune inhibition and represent therapeutic vulnerabilities in pancreatic ductal adenocarcinoma. Cancer Immunology, Immunotherapy. https://doi.org/10.1007/s00262-026-04479-9
Vancouver
Lin Y, Feng W, Li Y, Tang Y, Zhuang X, Huang Y, et al. NKG2A–HLA-E and TIM3–galectin 9 pathways promote immune inhibition and represent therapeutic vulnerabilities in pancreatic ductal adenocarcinoma. Cancer Immunology, Immunotherapy. 2026. doi:10.1007/s00262-026-04479-9
BibTeX
@article{Lin2026,
author = {Lin, Yuanyu and Feng, Wanhua and Li, Yan and Tang, Yisen and Zhuang, Xiaomei and Huang, Yingzi and Xie, Juping and Liu, Kai and Fan, Youwen and Tang, Yajun and Li, Dong and He, Ziming and Qiu, Yuxiong and Chen, Junzong and Xu, Jie and Yang, Zheng and Lan, Linxiang and Tang, Di and Deng, Gang and Zhou, Guoying},
title = {NKG2A–HLA-E and TIM3–galectin 9 pathways promote immune inhibition and represent therapeutic vulnerabilities in pancreatic ductal adenocarcinoma},
journal = {Cancer Immunology, Immunotherapy},
year = {2026},
doi = {10.1007/s00262-026-04479-9}
}
EUVIMED